You are not using a standards compliant browser. Because of this you may notice minor glitches in the rendering of this page. Please upgrade to a compliant browser for optimal viewing:
Internet Explorer 7
Safari (Mac and PC)
Kausik Datta

Comment on Winds of Change blow again
Dec 08, 2010, 11:37pm

Comment on They Love me in San Diego!
Nov 16, 2010, 6:21pm

Comment on They Love me in San Diego!
Nov 16, 2010, 1:26pm

Comment on Lola, or A Tale of Delightful Surprise
Oct 19, 2010, 9:46pm
Friends (0): See all?
User has no friends listed.
No groups on record
User Information
Post Doc
Immunology, Microbiology, Infectious diseases
Non-Scientific Interests:
Technology, Music, Marvel Universe, Mystery and Science Fiction, Movies
Education History
All India Institution of Medical Sciences
New Delhi, Delhi India
1/1997 - 6/2003
Work History
Johns Hopkins University School of Medicine
Baltimore, MD USA
9/2008 - 0/0
Postdoctoral Research Fellow
Description of Work:
Immunopathology of mycotic infections, with special emphasis on Aspergillus spp. and Cryptococcus spp.
Subramaniam KS Datta K Quintero E Manix C Marks MS Pirofski LA. 2010. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans..J. Immunol.. 184:5755-67
Subramaniam KS Datta K Marks MS Pirofski LA. 2010. Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans..Infect. Immun.. 78:441-52
Datta K Bartlett KH Marr KA. 2009. Cryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche... 2009:176532
Datta K Bartlett KH Baer R Byrnes E Galanis E Heitman J Hoang L Leslie MJ MacDougall L Magill SS Morshed MG Marr KA Mak S. 2009. Spread of Cryptococcus gattii into Pacific Northwest region of the United States..Emerging Infect. Dis.. 15:1185-91
Datta K Lees A Pirofski LA. 2008. Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan..Clin. Vaccine Immunol.. 15:1176-87
Datta K Pirofski LA. 2006. Towards a vaccine for Cryptococcus neoformans: principles and caveats..FEMS Yeast Res.. 6:525-36
Maitta RW Datta K Pirofski LA. 2004. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan..Vaccine. 22:4062-8
Maitta RW Datta K Chang Q Luo RX Witover B Subramaniam K Pirofski LA. 2004. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles..Infect. Immun.. 72:4810-8
Banerjee U Datta K Casadevall A. 2004. Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India..Med. Mycol.. 42:181-6
Maitta RW Datta K Lees A Belouski SS Pirofski LA. 2003. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice..Infect. Immun.. 72:196-208
Datta K Jain N Sethi S Rattan A Casadevall A Banerjee U. 2003. Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care..J. Antimicrob. Chemother.. 52:683-6
Banerjee U Datta K Majumdar T Gupta K. 2001. Cryptococcosis in India: the awakening of a giant?.Med. Mycol.. 39:51-67
Goswami R Dadhwal V Tejaswi S Datta K Paul A Haricharan RN Banerjee U Kochupillai NP. 2000. Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status..J. Infect.. 41:162-6